Skip to main content

14 July 2025

Last updated: Thursday 10 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

JAK2 inhibitors: a breakthrough in oncology?

Thursday 23 September 2010

Interviewee/Contributor

Jürg Eckhardt

Organisation

Bellevue Asset Management

Organisations

Pfizer Regenerative Medicine
Standards Coordinating Body
Hutchison China MediTech
Zealand Pharma A/S
Institute of Psychiatry, King's College Hospital
Inception Sciences Inc
SFL Regulatory Affairs & Scientific Communication GmbH
BonelliErede
Seventure Partners
VIB

Interviewees and Contributers

Lita Nelsen
Gerald Möller
Carlos Buesa
Ali Mortazavi
Robin Davison
Ralf Schmid and Emma Harvey
Clare Ozawa
Carl June
Bradley Bolzon
Arndt Schottelius

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Louise Peacock joins Aravax

Saturday 5 July 2025

Hans Menssen joins Priothera

Saturday 5 July 2025

Filippa Stenberg joins Mölnlycke Health Care

Saturday 5 July 2025

Commit Biologics appoints scientific advisory board

Saturday 5 July 2025

Cristina Csimma joins Asgard Therapeutics

Saturday 5 July 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form